Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the post-slider-and-carousel domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home1/qordata/stg.qordata.com/wp-includes/functions.php on line 6114
consent management, EFPIA, Pharma Compliance, Physician Engagement – qordata is a Data-Driven Compliance Platform Provider

Category: consent management, EFPIA, Pharma Compliance, Physician Engagement

Explore our library of blogs, insights, research papers, and more information on compliance in the life sciences industry.

In November 2020, The United States Department of Health and Human Services Office of Inspector General (OIG) issued a “Special Fraud Alert: Speaker Programs“. The Special Fraud Alert highlights the fraud and abuse risks associated with the offer, payment, solicitation, or receipt of remuneration relating to speaker programs by life sciences companies. It raises questions […]

Last week, qordata hosted an interactive webinar with Sarah DiFransesca from Dinsmore & Shohl LLP and Leslie Restanio from Amneal Pharmaceuticals for analyzing the recently rolled out OIG’s Special Fraud Alert for Speaker Programs. The Special Fraud Alert highlights the fraud and abuse risks associated with the offer, payment, solicitation, or receipt of remuneration relating […]

A short while ago, we conducted a survey on HCP Meal limits across the life sciences industry. The purpose of this survey was to get an idea about a general trend in HCP meal limits set by pharma and medical device manufacturing companies and share the findings so that compliance teams across the industry can […]

Recently, we hosted our Compliance Conversation series webinar titled “Evaluation of Corporate Compliance Program: What’s new in DOJ’s revised guidance?” with Heidi Kocher, a partner at Liles Parker PLLC. It was a hit, and many of the attendees emailed us to tell us that it was very updated information regarding DOJ’s revised guidelines for the […]

Speaker programs and meals with HCPs are a component of pharma and life sciences companies to educate HCPs about their drugs or medical devices. These activities also have a marketing angle as pharmaceuticals and medical device manufactures train HCPs on drug/device usage, benefits, risks, etc. However, the Sunshine Act makes it compulsory for the pharma […]

The Sunshine Act, a provision of the Affordable Care Act, requires life sciences organizations to report payments and other transfers of value to the Centers for Medicare and Medicaid Services (CMS). This information is then made publicly accessible on CMS’s website. The reporting process involves preparing aggregate spend reports according to a CMS-preferred format and […]